CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials
|<<... 24 25 26 27 28 29 30 ...>>|

Expert OpinionVolume 12, Issue 6, June 2019

JOURNAL：JACC: Cardiovascular Imaging Article Link

Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging?

LJ Shaw, JK Min, Y Chandrashekhar. Keywords: biomarker; CAD; hsTnI; coronary Imaging; high risk plaque;

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top